Jim Hollingshead
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jim Hollingshead
Jim Hollingshead is recorded as CEO at Insulet Corp (PODD). Jim Hollingshead was last confirmed as Board Member at Resmed Inc (RMD) in a filing dated October 5, 2022. Insulet Corp reported in an 8-K filed April 28, 2025 that Jim Hollingshead resigned as Insulet Board of Directors, effective April 28, 2025. Jim Hollingshead has spoken on 9 earnings calls across 1 company, most recently for Insulet Corp on February 20, 2025.
“Ms. McEvoy succeeds Jim Hollingshead, who has agreed with Insulet's Board of Directors that his employment with the Company will cease effective as of April 28, 2025, and resigned from the Insulet Board of Directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2022-10-05
Last confirmed by a filing; no departure on record
-
Resmed Inc (RMD)
Source not stated
Start not stated–2022-05-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Insulet Corp
Other people whose current roles at this company are on record from its filings.
- Ashley A. McEvoy CEO, Board Member
- Ashley McEvoy CEO, Board Member
- Timothy J. Scannell Chairman
- Flavia H. Pease CFO
- Flavia Pease CFO, Board Member
- Eric Benjamin COO
- Amit Guliani CTO
- Mark Field CTO
- John Kapples General Counsel
- Elizabeth Weatherman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.